ADVERTISEMENT

Potent Alternative

Reverse-engineered human stem cells may leapfrog the embryonic kind

Thomson and other developers of the new alchemy emphasize that embryonic stem cells remain invaluable research tools and will be crucial for confirming that iPS cells harbor no hidden limitations. Reprogrammed cells “might differ in clinically relevant ways from embryonic stem cells,” Thomson notes. “People want to rush and say we don’t need embryonic stem cells anymore, and over time that might be true, but right now that’s premature.”

Rights & Permissions
or subscribe to access other articles from the February 2008 publication.
Digital Issue $7.99
Digital Issue + All Access Subscription $99.99 Subscribe
Share this Article:

Comments

You must sign in or register as a ScientificAmerican.com member to submit a comment.

Email this Article

X